Qelbree (Viloxazine): A Non-Stimulant Option for ADHD
Back to Blog
ADHD

Qelbree (Viloxazine): A Non-Stimulant Option for ADHD

Next Step Psychiatry TeamFebruary 20245 min read

Not everyone with ADHD can or wants to take stimulant medications. At Next Step Psychiatry in Lilburn, we offer various treatment options including Qelbree—a newer non-stimulant medication approved for ADHD in children, adolescents, and adults.

What Is Qelbree?

Qelbree (viloxazine) is a selective norepinephrine reuptake inhibitor (SNRI) that increases norepinephrine availability in the brain, helping manage ADHD symptoms without the potential for abuse associated with stimulants.

Who Might Consider Qelbree?

Person in thoughtful reflection
  • Those who haven't responded well to stimulants
  • People concerned about stimulant side effects or abuse potential
  • Patients with conditions that contraindicate stimulants
  • Those who prefer non-controlled medication

Dosing

  • Children 6-11: Starting dose 100mg/day, max 400mg/day
  • Adolescents 12-17: Starting dose 200mg/day, max 400mg/day
  • Adults: Starting dose 200mg/day, max 600mg/day

Common Side Effects

Brain and mental health concept
  • Drowsiness (often improves over time)
  • Decreased appetite
  • Nausea
  • Headache
  • Insomnia
  • Fatigue

Benefits vs. Stimulants

  • No "crash" when medication wears off
  • Not a controlled substance—no abuse potential
  • Can be an option when stimulants aren't appropriate

ADHD Treatment Options

Our team can help determine if Qelbree or another medication is right for your ADHD.

Schedule an evaluation: 678-437-1659

4145 Lawrenceville Hwy STE 100, Lilburn, GA 30047

Schedule Appointment